Influence of glyco-oxidation on complexes between fibrin(ogen) and insulin-like growth factor-binding protein-1 in patients with diabetes mellitus type 2

Interaction between fibrinogen and insulin-like growth factor-binding protein-1 in human plasma under physiological conditions

(2016) N. Gligorijević et al.   BIOCHEMISTRY-MOSCOW

Advanced Glycation End Products Modulate Structure and Drug Binding Properties of Albumin

(2015) Saurabh Awasthi et al.   MOLECULAR PHARMACEUTICS

Oxidative Modification of Fibrinogen Is Associated With Altered Function and Structure in the Subacute Phase of Myocardial Infarction

(2014) M. Becatti et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Advanced Glycation End Products and Diabetic Complications

(2014) Varun Parkash Singh et al.   KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

A study on human serum albumin influence on glycation of fibrinogen

(2013) Martyna Kielmas et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Methylglyoxal induces oxidative stress and mitochondrial dysfunction in osteoblastic MC3T3-E1 cells

(2013) K. S. Suh et al.   FREE RADICAL RESEARCH

Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix

(2013) M. M. Martino et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Acetylation and glycation of fibrinogen in vitro occur at specific lysine residues in a concentration dependent manner: A mass spectrometric and isotope labeling study

(2012) Jan Svensson et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Insulin-Like Growth Factor Axis and Risk of Type 2 Diabetes in Women

(2012) S. N. Rajpathak et al.   DIABETES

Where does plasma methylglyoxal originate from?

(2012) Miklós Péter Kalapos   DIABETES RESEARCH AND CLINICAL PRACTICE

Reactive carbonyl compounds (RCCs) cause aggregation and dysfunction of fibrinogen

(2012) Ya-Jie Xu et al.   Protein & Cell

Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans

(2011) Terje Lund et al.   Diabetes & Vascular Disease Research

Diabetes mellitus and thrombosis

(2011) Natale Vazzana et al.   THROMBOSIS RESEARCH

Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): The Söderåkra Cardiovascular Risk Factor Study

(2009) U. Petersson et al.   DIABETES & METABOLISM

Factors Contributing to Increased Platelet Reactivity in People With Diabetes

(2009) D. J. Schneider   DIABETES CARE

Global estimates of the prevalence of diabetes for 2010 and 2030

(2009) J.E. Shaw et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes

(2009) Swapnil N. Rajpathak et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis

(2009) Stephen B. Wheatcroft et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control

(2007) Maura Lodovici et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS